Armistice Capital LLC Acquires New Stake in P3 Health Partners Inc. (NASDAQ:PIII)

Armistice Capital LLC acquired a new stake in P3 Health Partners Inc. (NASDAQ:PIII) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 7,900,000 shares of the company’s stock, valued at approximately $3,557,000.

A number of other large investors also recently bought and sold shares of PIII. GSA Capital Partners LLP boosted its holdings in shares of P3 Health Partners by 110.6% in the first quarter. GSA Capital Partners LLP now owns 565,522 shares of the company’s stock valued at $582,000 after acquiring an additional 296,936 shares in the last quarter. Renaissance Technologies LLC lifted its position in P3 Health Partners by 188.1% in the second quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock valued at $50,000 after purchasing an additional 73,000 shares during the period. Emfo LLC boosted its holdings in P3 Health Partners by 39.8% in the 2nd quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after purchasing an additional 406,418 shares in the last quarter. Finally, Sanders Morris Harris LLC increased its position in P3 Health Partners by 16.3% during the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock worth $64,000 after purchasing an additional 20,000 shares during the period. Hedge funds and other institutional investors own 7.75% of the company’s stock.

P3 Health Partners Stock Down 1.4 %

PIII opened at $0.38 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.69 and a quick ratio of 0.69. P3 Health Partners Inc. has a 12 month low of $0.35 and a 12 month high of $1.93. The stock has a market capitalization of $120.76 million, a P/E ratio of -0.65 and a beta of 1.17. The business has a 50 day simple moving average of $0.53 and a 200-day simple moving average of $0.61.

P3 Health Partners (NASDAQ:PIII) last released its earnings results on Wednesday, August 7th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.07). P3 Health Partners had a negative net margin of 4.95% and a negative return on equity of 43.19%. The business had revenue of $379.16 million during the quarter, compared to analyst estimates of $364.50 million. On average, equities analysts anticipate that P3 Health Partners Inc. will post -0.23 earnings per share for the current fiscal year.

Insider Activity at P3 Health Partners

In related news, major shareholder Pacific Founders Ugp I. Chicago bought 80,000 shares of the stock in a transaction on Friday, September 6th. The shares were bought at an average cost of $0.49 per share, for a total transaction of $39,200.00. Following the completion of the transaction, the insider now owns 76,785,438 shares of the company’s stock, valued at approximately $37,624,864.62. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders purchased 400,000 shares of company stock worth $205,600 over the last 90 days. Company insiders own 17.86% of the company’s stock.

P3 Health Partners Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.